KLRK1 and neoplasm: Findings of high NKG2DL expression in human colorectal, cervical, and nasopharyngeal carcinomas and its correlation with improved disease-free survival supported the role of NKG2D in anti-tumor immunity and the notion of NKG2D as a potential immunotherapy target [10].